Seeking Alpha

OSIRIS THERAPEUTICS (OSIR)

()

News & PR
Market Currents

Buzz
Twitter: OSIR

Business Intelligence
Transcripts
Events
Key Developments

Instablog posts on OSIR

Spectrum Pharmaceuticals: $50 Million Vote of Confidence or Cause for Concern by Justin M. Hall
On Friday, Spectrum Pharmaceuticals (SPPI) announced the company sold $50 million worth of common shares at $7.55. As is often the case when a company sells its shares the share price falls.Shares of SPPI closed down -4.39% to $7.18 in Friday trading.As result of this most recent offering... More »
September 18, 2009 • SPPI, ARIA, AGN
Lucky 13 Buys: \\\\ +43.87% //// in 9 Weeks by Justin M. Hall
On July 7, I introduced the Lucky 13 Buys to those who follow this blog regularly. One investor, Hustle617, gave it a shot and bought some of the Lucky 13 Buys. As result, he has earned some very impressive gains over the past two months. Nice... More »
September 16, 2009 • OSIR, UNG, PRXL
AND THE RESULTS ARE IN PAR DEUX . . . by Justin M. Hall
I track all of the BUY recommendations that I post on this blog. In the table below, I am providing the results of my recent BUY calls.LUCKY 13 BUYSThis portfolio of buys was posted on July 7, 2009. SymbolRec. DateRec.... More »
September 11, 2009 • OSIR, UNG, PRXL
Spectrum Pharmaceuticals: Post Zevalin Approval Sales Should Ramp Up by Justin M. Hall
As many, who have followed and/or invested in Spectrum Pharmaceuticals (SPPI), know Zevalin® was finally (and thankfully) approved last Friday, September 4 by the FDA for first-line consolidation use in patients with non-Hodgkins lymphoma (NHL). PRELIMINARY FACTSZevalin is the first of... More »
September 11, 2009 • BMY, PFE, OSIP
Suprisingly Priced: The Stem Cell Sector's Profit Leader (OTC: CCEL) by M. E. Garza
Early in August, I introduced you to Cryo-Cell International, Inc. (OTC: CCEL) , one of the largest and most established leaders in the stem cell sector. Today, we get to meet the company's CEO who shares some interesting insights and unpretended wisdom about the business and all of the exciting... More »
August 27, 2009 • CCEL, GERN, OSIR
Fuel Systems & Three Cancer Drug Makers by Justin M. Hall
The Lucky 13 Buys portfolio was introduced on July 7, 2009. In less than two months, this portfolio of carefully selected companies has gained nearly 30%. Three of the companies have achieved gains of greater than 53%. While almost ½ are up over 38%, more than ¾ of... More »
August 24, 2009 • FSYS, ONTY, TOMO
Banner (BANR), Osiris Therapeutics (OSIR) Rise on Sector Strength, Books-A-Million (BAMM) Gains on Strong Earnings by Small Cap Network
Banner (BANR) and Osiris Therapeutics (OSIR) rise as their sectors gain strength and Books-A-Million (BAMM) gains on strong second quarter earnings.Banner Corp., (BANR) jumped this morning on a stronger housing market and Osiris Therapeutics (OSIR) shares gained as the Stem Cell sector continued... More »
August 24, 2009 • BANR, OSIR, BAMM
Ariad Pharmaceuticals: Advancing in Front of Phase 3 Interim Look by Justin M. Hall
Ariad Pharmaceuticals (Nasdaq: ARIA): Advancing in Front of Phase 3 Interim Look The Lucky 13 Buys portfolio continues to advance. In the past two sessions, some of the companies have seen a dramatic rise in their share prices. View the results from Friday, July 24 in... More »
July 29, 2009 • ARIA, SPPI, ONTY
SuperGen Sizzled in July, Outlook for Spectrum Pharmaceuticals Remains Very Promising by Justin M. Hall
So far, the Lucky 13 Buys have been winners this month. Investors, who followed the market’s cues and placed their bets on small cap drug makers, have likely fared very well over the past two to three weeks. All of the companies on the Lucky 13 Buys list ended the third week of... More »
July 27, 2009 • SPPI, SUPG, FSYS
Lucky 13 Buys by Justin M. Hall
Listed below are stocks and ETFs that could likely generate attractive returns over the next 6-12 months. This is a merely a list which investors should begin their own research. ARIA CLNEFSYS GTXI ONB ONTY OSIR PRXL SPPI SUPG SWC TOMO UNG Disclosure: Long SPPI More »
July 7, 2009 • ARIA, UNG, TOMO

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

OSIRIS THERAPEUTICS (OSIR)

Instablog posts on OSIR

Spectrum Pharmaceuticals: $50 Million Vote of Confidence or Cause for Concern by Justin M. Hall

Lucky 13 Buys: \\\\ +43.87% //// in 9 Weeks by Justin M. Hall

AND THE RESULTS ARE IN PAR DEUX . . . by Justin M. Hall

Spectrum Pharmaceuticals: Post Zevalin Approval Sales Should Ramp Up by Justin M. Hall

Suprisingly Priced: The Stem Cell Sector's Profit Leader (OTC: CCEL) by M. E. Garza

Fuel Systems & Three Cancer Drug Makers by Justin M. Hall

Banner (BANR), Osiris Therapeutics (OSIR) Rise on Sector Strength, Books-A-Million (BAMM) Gains on Strong Earnings by Small Cap Network

Ariad Pharmaceuticals: Advancing in Front of Phase 3 Interim Look by Justin M. Hall

SuperGen Sizzled in July, Outlook for Spectrum Pharmaceuticals Remains Very Promising by Justin M. Hall

Lucky 13 Buys by Justin M. Hall

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers